Activin A Receptor, Type IIB (ACVR2B) (C-Term) Antikörper

Details zu Produkt Nr. ABIN635186
Antigen
Epitop
C-Term
11
10
9
9
8
7
7
7
7
4
4
4
3
3
3
3
2
1
1
1
1
Reaktivität
Human, Hund
111
58
32
7
6
6
6
6
5
3
3
3
3
2
2
2
1
Wirt
Kaninchen
110
13
3
Klonalität
Polyklonal
Konjugat
Unkonjugiert
14
5
5
4
4
4
2
2
2
2
2
2
1
1
1
1
1
Applikation
Western Blotting (WB)
95
49
38
13
9
4
2
2
2
1
1
1
Optionen
Immunogen ACVR2 B antibody was raised using the C terminal of ACVR2 corresponding to a region with amino acids HDAEARLSAGCVEERVSLIRRSVNGTTSDCLVSLVTSVTNVDLPPKESSI
Spezifität ACVR2 B antibody was raised against the C terminal of ACVR2
Reinigung Affinity purified
Antigen
Andere Bezeichnung ACVR2B (ACVR2B Antibody Abstract)
Hintergrund Activin receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling, and type II receptors are required for binding ligands and for expression of type I receptors.
Molekulargewicht 33 kDa (MW of target protein)
Pathways Hormone Transport, Cancer Immune Checkpoints
Applikations-hinweise WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator.
Kommentare

ACVR2B Blocking Peptide, catalog no. 33R-3706, is also available for use as a blocking control in assays to test for specificity of this ACVR2B antibody

Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ACVR0 antibody in PBS
Konzentration Lot specific
Buffer PBS
Handhabung Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.
Lagerung 4 °C
Informationen zur Lagerung Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
Bilder des Herstellers
Image no. 1 for anti-Activin A Receptor, Type IIB (ACVR2B) (C-Term) antibody (ABIN635186) ACVR2B antibody used at 0.25 ug/ml to detect target protein.